VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $57,280,470 | -9.2% | 2,960,231 | 0.0% | 18.66% | -13.5% |
| Q3 2022 | $63,083,000 | +56.6% | 2,960,231 | 0.0% | 21.57% | +67.2% |
| Q2 2022 | $40,289,000 | -41.9% | 2,960,231 | 0.0% | 12.90% | -34.4% |
| Q1 2022 | $69,299,000 | -11.8% | 2,960,231 | 0.0% | 19.66% | +3.3% |
| Q4 2021 | $78,535,000 | +52.9% | 2,960,231 | 0.0% | 19.03% | +63.3% |
| Q3 2021 | $51,360,000 | +33.4% | 2,960,231 | 0.0% | 11.66% | -2.1% |
| Q2 2021 | $38,513,000 | – | 2,960,231 | – | 11.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |